Pharma Pulse 7/18/24: Stigma, Price Point Major Obstacles for Widespread OTC Naloxone Use, RedBox Rx Launches Online Talk Therapy Services & more

Congress, Have a More Thoughtful, Bipartisan Pandemic Post-Mortem

Congress and our nation’s public health officials should take the current moment to self-reflect and resolve challenges with public confidence in our public and scientific institutions.

Expert: Stigma, Price Point Major Obstacles for Widespread OTC Naloxone Use

In an interview with Pharmacy Times, Allison Burns, president and CEO of EMO Health, details issues surrounding the price point of OTC naloxone and steps that can be taken to lower the price for patients. Additionally, Burns discusses the stigma around OTC naloxone and how overcoming this stigma is a huge step towards greater naloxone uptake.

Brain Startup Synchron Says AI Will Be Instrumental for Devices

Medical device maker has integrated OpenAI’s latest AI model into its technology.

RedBox Rx Launches Online Talk Therapy Services to Increase Access to Mental Health Care

RedBox Rx announced the launch of online talk therapy services to its platform. This service offering helps expand access to mental health care treatment across the country.

fda on Threads

We need diverse participants in mental health clinical trials. Here are three facts about clinical trials:

1⃣Participation is always voluntary

2⃣Trials often need healthy volunteers

3⃣Your safety is a priority

Learn more: fda.gov/consu…

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs